You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Hereditary Angioedema Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.
The global Hereditary Angioedema market size is projected to reach US$ 2724.1 million by 2027, from US$ 1786.9 million in 2020, at a CAGR of 7.3% during 2021-2027.
In terms of production side, this report researches the Hereditary Angioedema production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Hereditary Angioedema by regions (countries) and by Application.
The global Hereditary Angioedema market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Hereditary Angioedema market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Hereditary Angioedema markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Hereditary Angioedema market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Hereditary Angioedema market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Hereditary Angioedema market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Hereditary Angioedema market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Hereditary Angioedema market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Hereditary Angioedema market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Hereditary Angioedema market by each application segment for the same period.
This report includes the following manufacturers:
Pharming Group NV
Takeda
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Market Segment by Type
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Market Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Research Methodology
To compile the detailed study of the global Hereditary Angioedema market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Hereditary Angioedema market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Hereditary Angioedema market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Hereditary Angioedema Market Size Growth Rate by Type
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Market Segment by Application
1.3.1 Global Hereditary Angioedema Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Market Perspective
2.1 Global Hereditary Angioedema Market Size (2016-2027)
2.1.1 Global Hereditary Angioedema Revenue (2016-2027)
2.1.2 Global Hereditary Angioedema Sales (2016-2027)
2.2 Global Hereditary Angioedema Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Hereditary Angioedema Sales by Regions (2016-2021)
2.2.2 Global Hereditary Angioedema Revenue by Regions (2016-2021)
2.3 Global Hereditary Angioedema Market Size Forecast by Region
2.3.1 Global Hereditary Angioedema Sales Forecast by Region (2022-2027)
2.3.2 Global Hereditary Angioedema Revenue Forecast by Region (2022-2027)
2.4 Global Top Hereditary Angioedema Regions (Countries) Ranking by Market Size
2.5 Hereditary Angioedema Industry Trends
2.5.1 Hereditary Angioedema Market Trends
2.5.2 Hereditary Angioedema Market Drivers
2.5.3 Hereditary Angioedema Market Challenges
2.5.4 Hereditary Angioedema Market Restraints

3 Competitive Landscape by Manufacturers
3.1 Global Top Hereditary Angioedema Manufacturers by Sales (2016-2021)
3.1.1 Global Hereditary Angioedema Sales by Manufacturers (2016-2021)
3.1.2 Global Hereditary Angioedema Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Hereditary Angioedema Sales in 2020
3.2 Global Top Manufacturers Hereditary Angioedema by Revenue
3.2.1 Global Hereditary Angioedema Revenue by Manufacturers (2016-2021)
3.2.2 Top Hereditary Angioedema Manufacturers Covered: Ranking by Revenue
3.2.3 Global Hereditary Angioedema Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Hereditary Angioedema Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema as of 2020)
3.4 Global Hereditary Angioedema Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Hereditary Angioedema Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Hereditary Angioedema Market
3.7 Key Manufacturers Hereditary Angioedema Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Global Hereditary Angioedema Market Size by Type
4.1 Global Hereditary Angioedema Historic Market Review by Type (2016-2021)
4.1.1 Global Hereditary Angioedema Sales Market Share by Type (2016-2021)
4.1.2 Global Hereditary Angioedema Revenue Market Share by Type (2016-2021)
4.1.3 Hereditary Angioedema Price by Type (2016-2021)
4.2 Global Hereditary Angioedema Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hereditary Angioedema Sales Forecast by Type (2022-2027)
4.2.2 Global Hereditary Angioedema Revenue Forecast by Type (2022-2027)
4.2.3 Hereditary Angioedema Price Forecast by Type (2022-2027)

5 Global Hereditary Angioedema Market Size by Application
5.1 Global Hereditary Angioedema Historic Market Review by Application (2016-2021)
5.1.1 Global Hereditary Angioedema Sales Market Share by Application (2016-2021)
5.1.2 Global Hereditary Angioedema Revenue Market Share by Application (2016-2021)
5.1.3 Hereditary Angioedema Price by Application (2016-2021)
5.2 Global Hereditary Angioedema Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hereditary Angioedema Sales Forecast by Application (2022-2027)
5.2.2 Global Hereditary Angioedema Revenue Forecast by Application (2022-2027)
5.2.3 Hereditary Angioedema Price Forecast by Application (2022-2027)

6 North America
6.1 North America Hereditary Angioedema Sales Breakdown by Company
6.1.1 North America Hereditary Angioedema Sales by Company (2016-2027)
6.1.2 North America Hereditary Angioedema Revenue by Company (2016-2027)
6.2 North America Hereditary Angioedema Market Size by Type (2016-2027)
6.2.1 North America Hereditary Angioedema Sales by Type (2016-2027)
6.2.2 North America Hereditary Angioedema Revenue by Type (2016-2027)
6.3 North America Hereditary Angioedema Market Size by Application (2016-2027)
6.3.1 North America Hereditary Angioedema Sales by Application (2016-2027)
6.3.2 North America Hereditary Angioedema Revenue by Application (2016-2027)
6.4 North America Hereditary Angioedema Market Size by Country
6.4.1 North America Hereditary Angioedema Sales by Country (2016-2027)
6.4.2 North America Hereditary Angioedema Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Hereditary Angioedema Sales Breakdown by Company
7.1.1 Europe Hereditary Angioedema Sales by Company (2016-2027)
7.1.2 Europe Hereditary Angioedema Revenue by Company (2016-2027)
7.2 Europe Hereditary Angioedema Market Size by Type (2016-2027)
7.2.1 Europe Hereditary Angioedema Sales by Type (2016-2027)
7.2.2 Europe Hereditary Angioedema Revenue by Type (2016-2027)
7.3 Europe Hereditary Angioedema Market Size by Application (2016-2027)
7.3.1 Europe Hereditary Angioedema Sales by Application (2016-2027)
7.3.2 Europe Hereditary Angioedema Revenue by Application (2016-2027)
7.4 Europe Hereditary Angioedema Market Size by Country
7.4.1 Europe Hereditary Angioedema Sales by Country (2016-2027)
7.4.2 Europe Hereditary Angioedema Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Hereditary Angioedema Sales Breakdown by Company
8.1.1 Asia Pacific Hereditary Angioedema Sales by Company (2016-2027)
8.1.2 Asia Pacific Hereditary Angioedema Revenue by Company (2016-2027)
8.2 Asia Pacific Hereditary Angioedema Market Size by Type (2016-2027)
8.2.1 Asia Pacific Hereditary Angioedema Sales by Type (2016-2027)
8.2.2 Asia Pacific Hereditary Angioedema Revenue by Type (2016-2027)
8.3 Asia Pacific Hereditary Angioedema Market Size by Application (2016-2027)
8.3.1 Asia Pacific Hereditary Angioedema Sales by Application (2016-2027)
8.3.2 Asia Pacific Hereditary Angioedema Revenue by Application (2016-2027)
8.4 Asia Pacific Hereditary Angioedema Market Size by Regions
8.4.1 Asia Pacific Hereditary Angioedema Sales by Regions
8.4.2 Asia Pacific Hereditary Angioedema Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Hereditary Angioedema Sales Breakdown by Company
9.1.1 Latin America Hereditary Angioedema Sales by Company (2016-2027)
9.1.2 Latin America Hereditary Angioedema Revenue by Company (2016-2027)
9.2 Latin America Hereditary Angioedema Market Size by Type (2016-2027)
9.2.1 Latin America Hereditary Angioedema Sales by Type (2016-2027)
9.2.2 Latin America Hereditary Angioedema Revenue by Type (2016-2027)
9.3 Latin America Hereditary Angioedema Market Size by Application (2016-2027)
9.3.1 Latin America Hereditary Angioedema Sales by Application (2016-2027)
9.3.2 Latin America Hereditary Angioedema Revenue by Application (2016-2027)
9.4 Latin America Hereditary Angioedema Market Size by Country
9.4.1 Latin America Hereditary Angioedema Sales by Country (2016-2027)
9.4.2 Latin America Hereditary Angioedema Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Hereditary Angioedema Sales Breakdown by Company
10.1.1 Middle East and Africa Hereditary Angioedema Sales by Company (2016-2027)
10.1.2 Middle East and Africa Hereditary Angioedema Revenue by Company (2016-2027)
10.2 Middle East and Africa Hereditary Angioedema Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Hereditary Angioedema Sales by Type (2016-2027)
10.2.2 Middle East and Africa Hereditary Angioedema Revenue by Type (2016-2027)
10.3 Middle East and Africa Hereditary Angioedema Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Hereditary Angioedema Sales by Application (2016-2027)
10.3.2 Middle East and Africa Hereditary Angioedema Revenue by Application (2016-2027)
10.4 Middle East and Africa Hereditary Angioedema Market Size by Country
10.4.1 Middle East and Africa Hereditary Angioedema Sales by Country (2016-2027)
10.4.2 Middle East and Africa Hereditary Angioedema Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E

11 Company Profiles
11.1 Pharming Group NV
11.1.1 Pharming Group NV Corporation Information
11.1.2 Pharming Group NV Overview
11.1.3 Pharming Group NV Hereditary Angioedema Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Pharming Group NV Hereditary Angioedema Products and Services
11.1.5 Pharming Group NV Hereditary Angioedema SWOT Analysis
11.1.6 Pharming Group NV Recent Developments
11.2 Takeda
11.2.1 Takeda Corporation Information
11.2.2 Takeda Overview
11.2.3 Takeda Hereditary Angioedema Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Takeda Hereditary Angioedema Products and Services
11.2.5 Takeda Hereditary Angioedema SWOT Analysis
11.2.6 Takeda Recent Developments
11.3 CSL Limited
11.3.1 CSL Limited Corporation Information
11.3.2 CSL Limited Overview
11.3.3 CSL Limited Hereditary Angioedema Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 CSL Limited Hereditary Angioedema Products and Services
11.3.5 CSL Limited Hereditary Angioedema SWOT Analysis
11.3.6 CSL Limited Recent Developments
11.4 iBio Inc.
11.4.1 iBio Inc. Corporation Information
11.4.2 iBio Inc. Overview
11.4.3 iBio Inc. Hereditary Angioedema Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 iBio Inc. Hereditary Angioedema Products and Services
11.4.5 iBio Inc. Hereditary Angioedema SWOT Analysis
11.4.6 iBio Inc. Recent Developments
11.5 BioCryst Pharmaceuticals, Inc.
11.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
11.5.2 BioCryst Pharmaceuticals, Inc. Overview
11.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Products and Services
11.5.5 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema SWOT Analysis
11.5.6 BioCryst Pharmaceuticals, Inc. Recent Developments
11.6 Ionis Pharmaceuticals, Inc.
11.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
11.6.2 Ionis Pharmaceuticals, Inc. Overview
11.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Products and Services
11.6.5 Ionis Pharmaceuticals, Inc. Hereditary Angioedema SWOT Analysis
11.6.6 Ionis Pharmaceuticals, Inc. Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Hereditary Angioedema Value Chain Analysis
12.2 Hereditary Angioedema Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hereditary Angioedema Production Mode & Process
12.4 Hereditary Angioedema Sales and Marketing
12.4.1 Hereditary Angioedema Sales Channels
12.4.2 Hereditary Angioedema Distributors
12.5 Hereditary Angioedema Customers
13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Mar, 2021
  • NO OF PAGES: 105